[In response to 'Advances and controversies in the treatments of Alzheimer's disease']. [PDF]
González-Rodríguez VM +1 more
europepmc +1 more source
openNello studio delle malattie neurodegenerative come la malattia di Alzheimer, manca un modello animale che rappresenti l'intero spettro delle caratteristiche neuropatologiche umane.
GEROSA, SILVIA
core
Biomarker-Imaging Dissociation in Wild-Type Cardiac Amyloidosis after Treatment with Patisiran. [PDF]
Mesquita CT +7 more
europepmc +1 more source
Conflicting Clues in Severe LV Hypertrophy: An Unusual Presentation of ATTR Amyloidosis. [PDF]
Fernandes ASN, Faria J, Vieira CF.
europepmc +1 more source
Cognitive training effects in mild cognitive impairment with and without amyloid pathology. [PDF]
Bossa NA +4 more
europepmc +1 more source
To Silence or to Stabilize: That is the Question. [PDF]
Augusto JB.
europepmc +1 more source
Severe sinus node disease in patient with amyloid cardiomyopathy. [PDF]
Negreira-Caamaño M +2 more
europepmc +1 more source
Stroke caused by cerebral amyloid angiopathy: a case of difficult diagnosis. [PDF]
Gamarra RC +2 more
europepmc +1 more source
[Terapias dirigidas en amiloidosis cardíaca por transtiretina: una revisión del contexto clínico contemporáneo]. [PDF]
Costabel JP +5 more
europepmc +1 more source
Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence. [PDF]
Villacorta H, Villacorta AS.
europepmc +1 more source

